title: Reduced-intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT) for relapsed/refractory Hodgkin lymphoma (HL) in the brentuximab vedotin era: favorable overall and progression-free survival (OS/PFS) with low transplant-related mortality (TRM).
mesh_terms: D000328:Adult; D064591:Allografts; D000079963:Brentuximab Vedotin; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000401:mortality* / Q000628:therapy*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D033581:Stem Cell Transplantation; D015996:Survival Rate; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin